Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Hemispherx Biopharma Inc. 

One Penn Center
1617 JFK Boulevard
Philadelphia  Pennsylvania  19103  U.S.A.
Phone: 215-988-0080 Fax: 215-988-1739


 Company News
Hemispherx Biopharma (HEB)' Drug Ampligen Plus Intranasal Seasonal Influenza Vaccine Induces Cross-Reactive Antibody Formation Against Avian H5N1 And H7N9 Influenza HA In Humans 9/15/2014 8:11:04 AM
Hemispherx Biopharma (HEB) And The Swiss Department Of Defense, Civil Protection And Sports Expand Their Collaborative Research Agreement To Include The Study Of Alferon® And Ampligen® Against The Ebola Virus 9/10/2014 8:12:09 AM
Hemispherx Biopharma (HEB) And United States Army Medical Research Institute Of Infectious Diseases (USAMRIID) Agree To Collaborate In Studying Alferon® And Ampligen® Against The Ebola Virus 9/8/2014 8:00:40 AM
Hemispherx Biopharma (HEB) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City September 8-10th 9/3/2014 7:51:47 AM
Hemispherx Biopharma (HEB) Announces Financial Results For The Six Months Ended June 30, 2014 8/11/2014 7:45:33 AM
Hemispherx Biopharma (HEB)'s Two Drugs, Ampligen® And Alferon® Ranked Highly In Sensitivity Testing Against MERS/SARS Coronaviruses 8/4/2014 8:24:03 AM
Hemispherx Biopharma (HEB) Achieves High Ranking In Sensitivity Testing Against MERS/SARS Coronaviruses Compared To Other Drugs 7/22/2014 3:36:24 PM
Hemispherx Biopharma (HEB) And Bioclones, A Leading South African Biotechnology Company, Join Forces On Novel Therapeutic Cancer Vaccine 7/14/2014 7:58:45 AM
Hemispherx Biopharma (HEB) And Bioclones Join Forces In Effort To Eradicate HIV/AIDS Virus Based On Recent Clinical Insights Of Wistar Institute, University of Pennsylvania 7/8/2014 10:39:00 AM
Hemispherx Biopharma (HEB) To Present During The 2014 Biotechnology Industry Organization (BIO) International Convention June 26 6/25/2014 8:00:13 AM